Literature DB >> 25374425

Implication of matrix metalloproteinases in regulating neuronal disorder.

Abhishek Mukherjee1, Snehasikta Swarnakar.   

Abstract

Neurological disorder is an abnormal condition of the nervous system that occurs due to the structural and biochemical abnormalities of nerves in brain and spinal cord. The nervous system, once exposed, has a limited capacity of self-repair. Neurodegeneration refers to the phenomenon of the structural and functional loss of neurons and the rate of which is accelerated by aging. Recent studies identified the blood brain barrier as hotspot of damage due to neurodegeneration. Depending on the location and severity of damage, the neurons succumb to death through the apoptotic, autophagic and necrotic pathways. The neurological system reorients the structure of neuronal circuits in order to maintain the neuronal plasticity during neurological disorders like Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis etc. Matrix metalloproteinases (MMPs), a family of Zn(2+) dependent endopeptidases play an important role in those neurodegenerative disorders. Recent studies implicated the role of MMPs in acute neuroinflammatory damage as well as in chronic neurodegeneration. The critical function of individual MMPs in tissue repair is also very important. MMPs serve important functions in the central nervous system (CNS) during growth and development. Besides, MMPs are important in neuronal damage in acute and chronic conditions as well as repair processes. Studies reveal that MMPs and the tissue inhibitors of metalloproteinases (TIMPs) play pivotal roles in pathogenesis and recovery of neurons. The expression and activities of MMPs are regulated by signaling molecules, TIMPs, cell surface receptors and transcription factors. In this review, we attempt to elucidate the role of MMPs in neurodegeneration and their functional mechanism in repairing the CNS. We also provide information for the therapeutics in neuronal disorder in the perspective of MMP regulation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25374425     DOI: 10.1007/s11033-014-3752-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  126 in total

1.  Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy.

Authors:  H Siebert; N Dippel; M Mäder; F Weber; W Brück
Journal:  J Neuropathol Exp Neurol       Date:  2001-01       Impact factor: 3.685

Review 2.  Autophagy gone awry in neurodegenerative diseases.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

Review 3.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

4.  Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.

Authors:  Ping Yan; Xiaoyan Hu; Haowei Song; Kejie Yin; Randall J Bateman; John R Cirrito; Qingli Xiao; Fong F Hsu; John W Turk; Jan Xu; Chung Y Hsu; David M Holtzman; Jin-Moo Lee
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

5.  Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

Authors:  J R Backstrom; G P Lim; M J Cullen; Z A Tökés
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

6.  Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia.

Authors:  Santiago Rivera; Crystel Ogier; Jérôme Jourquin; Serge Timsit; Arkadius W Szklarczyk; Karen Miller; Andrew J H Gearing; Leszek Kaczmarek; Michel Khrestchatisky
Journal:  Eur J Neurosci       Date:  2002-01       Impact factor: 3.386

7.  Friedrich Heinrich Lewy (1885-1950) and his work.

Authors:  Bernd Holdorff
Journal:  J Hist Neurosci       Date:  2002-03       Impact factor: 0.529

8.  Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor.

Authors:  C C Solorzano; R Ksontini; J H Pruitt; P J Hess; P D Edwards; A Kaibara; A Abouhamze; T Auffenberg; R E Galardy; J N Vauthey; E M Copeland; C K Edwards; G Y Lauwers; M Clare-Salzler; S L MacKay; L L Moldawer; D D Lazarus
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

9.  Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures.

Authors:  Naoko Suenaga; Takashi Ichiyama; Masaya Kubota; Hiroshi Isumi; Jun Tohyama; Susumu Furukawa
Journal:  J Neurol Sci       Date:  2007-10-24       Impact factor: 3.181

Review 10.  Apoptosis, oncosis, and necrosis. An overview of cell death.

Authors:  G Majno; I Joris
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

View more
  4 in total

Review 1.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

2.  Skin Mirrors Brain: A Chance for Alzheimer's Disease Research.

Authors:  Christos C Zouboulis; Evgenia Makrantonaki; Amir M Hossini
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  A Novel Role of Prolidase in Cocaine-Mediated Breach in the Barrier of Brain Microvascular Endothelial Cells.

Authors:  Binah Baht Ysrayl; Muthukumar Balasubramaniam; Ife Albert; Fernando Villalta; Jui Pandhare; Chandravanu Dash
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

Review 4.  Diagnostic and Therapeutic Roles of Extracellular Vesicles in Aging-Related Diseases.

Authors:  Zixuan Sun; Xiaomei Hou; Jiaxin Zhang; Jiali Li; Peipei Wu; Lirong Yan; Hui Qian
Journal:  Oxid Med Cell Longev       Date:  2022-08-08       Impact factor: 7.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.